WAIKOLOA, Hawaii — Understanding how pregnancy may yield ocular changes will help ophthalmologists put together an effective treatment plan, according to a speaker at Retina 2026.While most changes in vision caused by pregnancy are temporary, some cond…
Proper differential diagnosis imperative in neuro-ophthalmology
WAIKOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2026, Andrew G. Lee, MD, discusses best practices for “setting the bar” and avoiding malpractice in neuro-ophthalmology.“There is a literal bar separating you from the jury, the judg…
FDA Makes Ianalumab a Breakthrough Therapy for Sjögren’s
Results from two clinical trials on ianalumab for Sjögren disease show favorable safety and adverse event outcomes, contributing to this designation. Medscape Medical News
FDA Makes Ianalumab Breakthrough for Sjögren Disease
Results from two clinical trials on ianalumab for Sjögren disease show favorable safety and adverse event outcomes, contributing to this designation. Medscape Medical News
As Private Equity Sells Out, Will Eye Practices Fare Better?
PE ownership of ophthalmology practices has reshaped physician opportunities and patient care. Will things change with publicly held companies buying them out? Medscape Medical News
Peter N. Slack receives Lindstrom Leadership Award
WAIKOLOA, Hawaii — Peter N. Slack, president and CEO of the Wyanoke Group, was honored with the annual Lindstrom Leadership Award and Lecture at Hawaiian Eye 2026.Vance Thompson, MD, who delivered the award alongside David F. Chang, MD, said that Slack…